Page 6 of 9 SEC Filing Item 1(a) Name of Issuer: Celator Pharmaceuticals, Inc. Item 1(b) Address of Issuer’s Principal Executive Offices: 200 PrincetonSouth Corporate Center, Suite 180, Ewing, New Jersey 08628 Item 2(a) Name of Person Filing: This statement is filed by: (i) Point72 Asset Management, L.P. (“Point72 Asset Management”) with respect to shares of Common Stock, $0.001 par value per share (“Shares”), of the Issuer held by certain investment funds it manages; (ii) Point72 Capital Advisors, Inc. (“Point72 Capital Advisors Inc.”) with respect to Shares held by certain investment funds managed by Point72 Asset Management; (iii) EverPoint Asset Management, LLC (“EverPoint Asset Management”) with respect to Shares held by certain investment funds it manages; and (iv) Steven A. Cohen with respect to Shares beneficially owned by Point72 Asset Management, Point72 Capital Advisors Inc., and EverPoint Asset Management. Point72 Asset Management, Point72 Capital Advisors Inc., EverPoint Asset Management and Steven A. Cohen have entered into a Joint Filing Agreement, a copy of which is filed with this Schedule 13G as Exhibit 99.1, pursuant to which they have agreed to file this Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Act. Item 2(b) Address or Principal Business Office: The address of the principal business office of (i) Point72 Asset Management, Point72 Capital Advisors Inc. and Mr. Cohen is 72 Cummings Point Road, Stamford, CT 06902; and (ii) EverPoint Asset Management is 510 Madison Avenue, New York, NY 10022. Item 2(c) Citizenship: Point72 Asset Management is a Delaware limited partnership. Point72 Capital Advisors Inc. is a Delaware corporation. EverPoint Asset Management is a Delaware limited liability company. Mr. Cohen is a United States citizen.
Follow Celator Pharmaceuticals Inc (NASDAQ:NONE)
Follow Celator Pharmaceuticals Inc (NASDAQ:NONE)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
| Item 1(a) | Name of Issuer: |
| Celator Pharmaceuticals, Inc. | |
| Item 1(b) | Address of Issuer’s Principal Executive Offices: |
| 200 PrincetonSouth Corporate Center, Suite 180, Ewing, New Jersey 08628 | |
| Item 2(a) | Name of Person Filing: |
| This statement is filed by: (i) Point72 Asset Management, L.P. (“Point72 Asset Management”) with respect to shares of Common Stock, $0.001 par value per share (“Shares”), of the Issuer held by certain investment funds it manages; (ii) Point72 Capital Advisors, Inc. (“Point72 Capital Advisors Inc.”) with respect to Shares held by certain investment funds managed by Point72 Asset Management; (iii) EverPoint Asset Management, LLC (“EverPoint Asset Management”) with respect to Shares held by certain investment funds it manages; and (iv) Steven A. Cohen with respect to Shares beneficially owned by Point72 Asset Management, Point72 Capital Advisors Inc., and EverPoint Asset Management. | |
| Point72 Asset Management, Point72 Capital Advisors Inc., EverPoint Asset Management and Steven A. Cohen have entered into a Joint Filing Agreement, a copy of which is filed with this Schedule 13G as Exhibit 99.1, pursuant to which they have agreed to file this Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Act. | |
| Item 2(b) | Address or Principal Business Office: |
| The address of the principal business office of (i) Point72 Asset Management, Point72 Capital Advisors Inc. and Mr. Cohen is 72 Cummings Point Road, Stamford, CT 06902; and (ii) EverPoint Asset Management is 510 Madison Avenue, New York, NY 10022. | |
| Item 2(c) | Citizenship: |
| Point72 Asset Management is a Delaware limited partnership. Point72 Capital Advisors Inc. is a Delaware corporation. EverPoint Asset Management is a Delaware limited liability company. Mr. Cohen is a United States citizen. | |
Follow Celator Pharmaceuticals Inc (NASDAQ:NONE)
Follow Celator Pharmaceuticals Inc (NASDAQ:NONE)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
